Reprise

Most teams looking at Reprise vs Vivun are not actually choosing between two presales tools — they are deciding which presales problem they have. Reprise builds the demo artifact your AE sends before SE handoff. Vivun manages the SE operating model after handoff and reports up to the VP of Sales Engineering. Pick the one that matches your binding constraint, or — if you are a mature enterprise SE org — accept that you will eventually buy both.

Typical fit: who each tool is built for

Typical Reprise customer

Enterprise SaaS with 100+ early-stage opportunities per quarter where SE coverage caps velocity. Regulated buyers (financial services, healthcare, public sector) who refuse sandbox access. AE motion where a personalized leave-behind measurably moves multi-threading and next-meeting rate. Budget band: mid-five to low-six figures annual; ROI mechanic is SE hours saved per early-stage opp.

Typical Vivun customer

Series D+ SaaS with 10+ named Sales Engineers and a VP-level sponsor. Salesforce as system of record with opportunity stages mature enough that utilization rollups survive an executive QBR. Documented RFP / security-questionnaire workload — Hero AI drafting against a real answer library. Technical win/loss reporting is a recurring board ask. Enterprise-only budget defended by SE leadership, not sales productivity ROI.

Neither if you're…

• Series A–C AE-led with no formal SE team — start with Walnut for the demo artifact and track SE capacity in a shared sheet.
• A forecast / revenue intelligence problem dressed up as a presales problem — see Clari.
• A team that needs live, cursor-on-real-product meetings rather than click-through clones — see Demodesk.

When Reprise wins

Reprise wins when the demo artifact is the binding constraint.

• SE bandwidth caps demo coverage. SEs are deferring early-stage demos because volume exceeds capacity. Reprise lets AEs ship a tailored demo without an SE in the loop — if AEs cannot self-serve the personalization, the price does not pencil.
• Security-conscious buyers. Regulated prospects refuse sandbox access. Reprise's clone fidelity on multi-step flows is the enterprise differentiator versus Walnut and Saleo.
• Multi-threading via leave-behind. A demo link forwarded to three buying-committee members generates three engagement signals on the opportunity, feeding AE MEDDIC capture with real champion-behavior evidence.

System view on Reprise: input = SE-captured product session + CRM context; AI step = personalization-at-scale + clone variants; human review = SE validates the clone, AE picks the right demo per persona; writeback = engagement events to Salesforce / HubSpot opportunity, Slack to deal channel, sequence handoff via Outreach / Salesloft; metric = SE hours saved, demo-to-next-meeting rate, multi-threading depth.

When Vivun wins

Vivun wins when the SE operating model is the binding constraint — utilization, technical win/loss, and RFP throughput have become metrics someone defends in QBRs.

• SE utilization is reportable, not anecdotal. With 10+ SEs, capacity is a real number. The Salesforce-native object model captures technical activities at the opportunity grain so the VP SE can defend hiring and territory coverage with data.
• Technical win/loss as a data product. The category's actual moat — this dataset does not exist in Gong, Salesforce reports, or generic BI. Pattern recognition on technical-loss reasons is what makes Vivun a presales OS, not a productivity feature.
• Hero AI on a clean opportunity corpus. Drafts RFP answers, opportunity briefs, and technical follow-ups against your prior activity library. Throughput leverage on a workload that otherwise scales linearly with deals.

System view on Vivun: input = Salesforce opportunities + technical activities + optional Gong/Chorus; AI step = Hero AI drafts RFPs, summaries, capacity rollups; human review = SE edits drafts, VP SE validates rollups before exec dashboards; writeback = Salesforce opportunity fields, Jira escalations, weekly leadership reports; metric = technical win rate, SE utilization %, RFP turnaround, technical-loss trend.

When you need both

Common at enterprise scale. Reprise owns the artifact; Vivun owns the workflow. Reprise feeds demo-engagement events to the Salesforce opportunity; Vivun reads those events into the technical-activity record. Done well this gives the VP SE a defensible view of which demo variants correlate with technical wins — neither tool answers that alone.

Coexistence rules:

• One owner per writeback contract. SE leadership owns Vivun's opportunity schema; Sales Ops or Demand Gen owns Reprise's demo-engagement events.
• Do not let Vivun's "demo intelligence" view compete with the Reprise library. Same data, different grain — make the joining contract explicit.
• Pair both with Gong or Chorus to validate what actually happened on calls. Demo engagement + call evidence is the closest a presales org gets to a real causal story.

Pricing and per-account math

Neither vendor publishes self-serve pricing. Reprise lands in mid-five to low-six figures per year per operator threads, scaling on seats, environments, and personalization volume.^[1] Vivun is enterprise-only — Hero AI is a separate line item; expect a 6-figure annual commitment at typical Series D+ SE org sizes.^[2]

Per-account math sanity check (illustrative, not invented dollars): if your SE team declines ~40% of early-stage demo requests, Reprise's value equation is SE hours unlocked × loaded SE cost — typically clear ROI inside one quarter at enterprise scale. Vivun's value equation is harder: utilization gain across 10+ SEs plus RFP throughput plus technical-loss reduction. Do not buy Vivun on Hero AI productivity alone; the analytics layer is the load-bearing economics. Reforecast both year two before year one ends — Reprise grows with marketing/AE seats; Vivun balloons when SE leadership rolls it out globally.

Feature overlap and gaps

Almost no functional overlap beyond the Salesforce surface. The wedge is artifact vs. operating model.

The buying mistakes we see most

1. Buying Vivun when the real pain is the demo artifact. No SE utilization problem but lots of "we cannot demo every early-stage opp" friction. Cost: 6-figure annual contract plus the actual demo tool bought anyway. Fix: name the binding constraint before the procurement call.
2. Buying Reprise expecting SE utilization analytics. Demo engagement is not SE-hours-against-opportunity. Cost: VP SE still cannot answer "are we over-allocated on Enterprise?" Fix: keep capacity tracking in a sheet until SE headcount crosses 10.
3. Rolling Vivun out without VP SE commitment. RevOps buys it for the dashboards; SEs treat it as compliance overhead; data rots within two quarters. Fix: do not buy Vivun without a VP-level SE leader as executive sponsor.

What to test in week 1

Reprise one-week test: pick one persona where SEs are declining early-stage demos. Quantify weekly volume. SE captures one golden-path demo (time-box to one working day). AE ships it as the leave-behind on the next 10 early-stage opps with token personalization. Track open rate, multi-threaded-viewer rate, and next-meeting rate vs. the prior 10 opps that got live demos. If multi-threading is flat, the leave-behind is not being forwarded — that is an AE-enablement gap.

Vivun one-week test: pick one revenue-tied metric (e.g., "technical win rate on Enterprise segment last 90 days" or "RFP turnaround for deals >$100K ACV"). Audit Salesforce for the worst hygiene gap and fix it. Build the report in Vivun and manually verify 10 opportunities against SFDC records. Have one SE draft one RFP section with Hero AI and track time-to-final vs. baseline. If the underlying SFDC data cannot support the report, do not roll Vivun out — fix opportunity model and SE activity discipline first.

Migration and coexistence

Coexistence is the common end state at enterprise scale. Reprise on the artifact, Vivun on the workflow, both writing to the same Salesforce opportunity. Document the writeback contract — which tool owns which custom field, Slack channel, Jira project — before either rolls out org-wide.

Reprise without Vivun: common at Series C–D where AE-led demo coverage is the only acute pain. Track SE capacity in a sheet; revisit Vivun at the next hiring tier.

Vivun without Reprise: rarer; SE org runs live-demo motions and skips the interactive-demo artifact category. Risk: SE bandwidth is still spent on every early-stage demo — Vivun reports on it but does not unlock it.

Migration between them is not a thing. They are not substitutes. If you are evaluating both at signature, scope each on its own ROI model — do not let one tool's pricing justify the other.

FAQ

Is Vivun a Reprise replacement? No. Vivun does not build interactive demos. "Demo intelligence" reports on which demos correlate with wins; it does not create them.

Is Reprise a Vivun replacement? No. Reprise tracks engagement on demo viewers, not SE utilization or technical win/loss. Treating Reprise reporting as a presales OS substitute leaves the VP SE without the data they need.

Can a 5-SE team get value from either? Reprise can pencil with a small SE team if the demo artifact is genuinely the constraint and AE volume is high. Vivun rarely pencils below 10 named SEs — utilization signal is too noisy.

Does Hero AI replace SEs on RFPs? No. Hero drafts; every customer-facing output needs SE review. Leverage is throughput, not headcount reduction.

How do these compare to Walnut? Walnut is the SMB-friendly answer to Reprise on the artifact side — see Walnut vs Reprise and Vivun vs Walnut. Walnut does not compete with Vivun.

Should we wire both into Outreach / Salesloft? Yes for Reprise (demo share links in cadences). Vivun integrates with sequencers for context, not cadence execution.